InVivoMAb anti-human NKG2D (CD314)
BE0351
ApplicationsFlow Cytometry, ImmunoPrecipitation, Neutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-human NKG2D (CD314)
- Delivery Days Customer7
- ApplicationsFlow Cytometry, ImmunoPrecipitation, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID1D11
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG1
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Pereira BI, De Maeyer RPH, Covre LP, et al. Sestrins induce natural killer function in senescent-like CD8(+) T cells. Nat Immunol. 2020,21(6):684-694. doi: 10.1038/s41590-020-0643-3Read this paper
- Parsons MS, Richard J, Lee WS, et al. NKG2D Acts as a Co-Receptor for Natural Killer Cell-Mediated Anti-HIV-1 Antibody-Dependent Cellular Cytotoxicity. AIDS Res Hum Retroviruses. 2016,32(10-11):1089-1096.Read this paper
- Zheng J, Wu WL, Liu Y, et al. The Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized Mice. PLoS One. 2015,10(8):e0135999. doi: 10.1371/journal.pone.0135999Read this paper
- Groh V, Rhinehart R, Randolph-Habecker J, et al. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol. 2001,2(3):255-60.Read this paper
- Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999,285(5428):727-9.Read this paper
